PRN: Glycomics/Glycobiology Market to Reach $2.1 Billion by 2025 - Aided by the Escalating Popularity of Personalized Medicines - Research and Markets

24/mag/2017 20:00:29 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Glycomics/Glycobiology Market to Reach $2.1 Billion by 2025 - Aided by the Escalating Popularity of Personalized Medicines - Research and Markets


DUBLIN, May 24, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Glycomics/Glycobiology Market, 2014-2025" report to their offering.


The global glycomics/glycobiology market is expected to reach USD 2.1 billion by 2025. Increasing investment in R&D by research institutes and pharmaceutical & biotechnology companies has been a major factor driving market growth. In addition, technological advancement has led to increased demand for advanced glycomics products for drug discovery & development, diagnostics, and oncology research.

Escalating popularity of personalized medicines for the treatment of several severe chronic diseases and genetic disorders is another major factor contributing toward the growth. Personalized medicines involve the application of glycomics for the study of structure and function of glycans that are attached to biomolecules. Glycans play a crucial role in modulating various biological processes and their assessment can help determine the susceptibility to diseases & response to treatment. Thus, application of glycobiology products is expected to rise in near future, owing to their high potential in personalized medicine.

Untapped opportunities in developing regions, including Asia Pacific and Africa, are another major factor supporting the growth of the glycomics market. Glycomics research is important for comprehensive study of glycomes to understand the cellular signaling pathways, cell functions, genetic structure, and physiological & pathological aspects. Glycomics research has become more popular these days due to its advantages over genomic/proteomic analysis that cannot be used to study many pathological processes. Thus, the demand for advanced glycomics products by researchers and healthcare professionals is expected to fuel the sector growth.

Companies Mentioned

  • Danaher
  • Agilent Technologies
  • Thermo Fisher Scientific, Inc.
  • ProZyme
  • Shimadzu Corporation
  • Bruker
  • Merck KGaA
  • Takara Bio, Inc.
  • New England Biolabs
  • Waters Corporation

Key Topics Covered:

1 Research Methodology

2 Executive Summary

3 Glycomics/Glycobiology Market Variables, Trends & Scope
4 Glycomics/Glycobiology: Product Estimates & Trend Analysis

5 Glycomics/Glycobiology: Application Estimates & Trend Analysis
6 Glycomics/Glycobiology: End-use Estimates & Trend Analysis

7 Glycomics/Glycobiology: Regional Estimates & Trend Analysis, by Product, Application, End-use

8 Competitive Landscape

For more information about this report visit

Media Contact:

Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


blog comments powered by Disqus è un servizio offerto da Factotum Srl